16 July 2021, 11:07 pm
A new antibody treatment is currently in development. Medical researchers behind the innovation claim that the new technology could be effective when it comes to neutralizing new strains of COVID-19, especially the spreading Delta and Lambda variants.
(Photo : Photograb from Diana Polekhina on Unsplash )
New Antibody Treatment Could Neutralize COVID-19 Delta and Lambda Variant Experts Claim It Offers 100% Survival Rate!
The new monoclonal antibody treatment is one of the medical innovations developed by Celltrion Group, one of the largest firms in the Korean pharmaceutical industry. The company s new regdanvimab or CT-P59 antibody treatment is claimed to have a strong neutralizing effect against new strains of the novel coronavirus.
United-states
Mexico
Germany
Argentina
Brazil
Ecuador
Chile
Peru
Spain
Griffin-davis
World-health-organization
Celltrion-group